We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

281 hedge funds and large institutions have $3.92B invested in Ionis Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 60 increasing their positions, 118 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more call options, than puts

Call options by funds: $92.4M | Put options by funds: $58.2M

54% more capital invested

Capital invested by funds: $2.54B → $3.92B (+$1.38B)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

2% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 45

0% less funds holding

Funds holding: 282 → 281 (-1)

49% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 118

Holders
281
Holders Change
-1
Holders Change %
-0.35%
% of All Funds
7.5%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
46
Increased
60
Reduced
118
Closed
45
Calls
$92.4M
Puts
$58.2M
Net Calls
+$34.2M
Net Calls Change
+$4.39M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$83.7M
2
Millennium Management
Millennium Management
New York
+$50.3M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$22.1M
4
PHS
PFM Health Sciences
California
+$20.3M
5
Citadel Advisors
Citadel Advisors
Florida
+$10.9M

Top Sellers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
-$45.4M
2
State Street
State Street
Massachusetts
-$20.7M
3
BI
BVF Inc
California
-$19.8M
4
JHIU
Janus Henderson Investors US
Colorado
-$15M
5
ClearBridge Investments
ClearBridge Investments
New York
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of New Jersey Common Pension Fund D
76
State of New Jersey Common Pension Fund D
New Jersey
$3.66M – – –
IHM
77
Iguana Healthcare Management
New York
$3.66M +$3.13M +100,000 New
ICM
78
IronBridge Capital Management
Illinois
$3.44M +$279K +8,915 +10%
Natixis Advisors
79
Natixis Advisors
Massachusetts
$3.34M -$195K -6,230 -6%
CS
80
Candriam SCA
Luxembourg
$3.3M +$2.82M +90,000 New
HCM
81
Highbridge Capital Management
New York
$3.13M +$2.68M +85,500 New
TRSOTSOK
82
Teachers Retirement System of the State of Kentucky
Kentucky
$2.96M +$2.52M +80,676 New
ProShare Advisors
83
ProShare Advisors
Maryland
$2.92M -$448K -14,326 -15%
State of Wisconsin Investment Board
84
State of Wisconsin Investment Board
Wisconsin
$2.82M -$93.9K -3,000 -4%
OPPM
85
Opus Point Partners Management
New York
$2.8M +$174K +5,571 +8%
AllianceBernstein
86
AllianceBernstein
Tennessee
$2.76M -$607K -19,415 -21%
APG Asset Management
87
APG Asset Management
Netherlands
$2.74M -$2.15M -68,700 -48%
Two Sigma Advisers
88
Two Sigma Advisers
New York
$2.61M -$2.96M -94,500 -57%
JCP
89
Jabre Capital Partners
Switzerland
$2.56M -$297K -9,500 -12%
NSEDCP
90
NJ State Employees Deferred Compensation Plan
New Jersey
$2.56M – – –
TCM
91
Tanaka Capital Management
New York
$2.37M +$2.03M +64,770 New
BA
92
BlackRock Advisors
Delaware
$2.32M -$2.93M -93,578 -60%
BBA
93
BLB&B Advisors
Pennsylvania
$2.31M -$25K -800 -1%
PA
94
Profund Advisors
Maryland
$2.27M -$99.9K -3,193 -5%
BBA
95
Baker Bros. Advisors
New York
$2.09M – – –
Canada Pension Plan Investment Board
96
Canada Pension Plan Investment Board
Ontario, Canada
$1.88M +$432K +13,800 +37%
BNP Paribas Financial Markets
97
BNP Paribas Financial Markets
France
$1.87M +$1.03M +32,982 +182%
FLAM
98
First Light Asset Management
Minnesota
$1.86M +$1.59M +50,782 New
Ohio Public Employees Retirement System (OPERS)
99
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.83M +$172K +5,493 +12%
KCM
100
Kennedy Capital Management
Missouri
$1.83M +$1.56M +50,000 New
2 3
4
5 6

IONS Hedge Fund Activity: Q3 2016 in Review

281 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q3 2016, worth a combined $3.92B — up 54% from $2.54B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IONS positions and 45 closed out — a net gain of 1 holder — while 60 added to existing stakes and 118 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $83.7M. The largest seller was AQR Capital Management, cutting an estimated $45.4M.

  • 281 institutional investors held Ionis Pharmaceuticals (IONS) as of Q3 2016, down from 282 in Q2 2016.
  • Funds reported $3.92B of Ionis Pharmaceuticals stock for Q3 2016, up 54% quarter-over-quarter.
  • 46 funds opened new Ionis Pharmaceuticals positions in Q3 2016 and 45 closed out, a net change of +1 holder.
  • The largest Ionis Pharmaceuticals buyer in Q3 2016 was Wellington Management Group, an estimated $83.7M added.
  • The largest Ionis Pharmaceuticals seller in Q3 2016 was AQR Capital Management, an estimated $45.4M sold.

Based on aggregated 13F filings for Q3 2016.